清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

LBA1 Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III NSCLC: Final results from PACIFIC-2

杜瓦卢马布 阶段(地层学) 放化疗 医学 肿瘤科 内科学 总体生存率 癌症 地质学 古生物学 免疫疗法 无容量
作者
Jeffrey D. Bradley,Shunichi Sugawara,K.H. Lee,Gyula Ostoros,Ahmet Demirkazık,Milada Zemanová,Virote Sriuranpong,Ana Caroline Zimmer Gelatti,J. Menezes,Bogdan Żurawski,Michael Newton,P. Chander,Nan Jia,Zofia F. Bielecka,Mustafa Özgüroĝlu
出处
期刊:ESMO open [Elsevier BV]
卷期号:9: 102986-102986 被引量:23
标识
DOI:10.1016/j.esmoop.2024.102986
摘要

The PACIFIC trial established consolidation durvalumab (D) after chemoradiotherapy (CRT) as SoC for pts with unresectable stage III NSCLC. However, up to 30% of pts are ineligible due to progression during/shortly after CRT or inadequate recovery from CRT-related toxicity. The phase III PACIFIC-2 trial evaluated D initiated concurrently with platinum-based concurrent CRT (cCRT) followed by consolidation D, compared with cCRT alone, in pts with unresectable stage III NSCLC. PACIFIC-2 (NCT03519971) was a randomized double-blind study. Treatment (Tx)-naïve pts with WHO PS 0/1 and histologically/cytologically confirmed stage III NSCLC were randomized (2:1) to receive SoC cCRT concurrently with D or placebo (PBO) IV Q4W, stratified by age and disease stage. Pts then received consolidation D/PBO until progression, unacceptable toxicity, consent withdrawal, or other discontinuation criteria. The primary endpoint was PFS (BICR; RECIST v1.1). 327/328 randomized pts received Tx (D arm, n=219; PBO arm, n=108). A higher % of pts in the D vs PBO arm had T4 tumors (57.5% vs 48.6%) and squamous histology (55.3% vs 47.7%). As of 7 Sep 2023 (data cutoff), median follow-up in all (censored) pts was 30.5 (55.5) months. There was a trend (not statistically significant) toward improved PFS with D vs PBO (HR, 0.85; 95% CI: 0.65–1.12; P=0.247); median PFS was 13.8 vs 9.4 months. There was no significant difference in OS (HR, 1.03; 95% CI: 0.78–1.39; P=0.823); median OS was 36.4 vs 29.5 months. Max grade 3/4 any-cause AEs occurred in 53.4% vs 59.3% with D vs PBO; 25.6% vs 12.0% had AEs that led to discontinuation of D/PBO (14.2% vs 5.6% in the first 4 months); 47.0% vs 51.9% had serious AEs; and 13.7% vs 10.2% had AEs with outcome of death. Pneumonitis/radiation pneumonitis occurred in 28.8% vs 28.7%. In PACIFIC-2, concurrent D and CRT did not improve outcomes vs CRT alone. Overall, safety and tolerability were consistent with the known profiles for D and CRT, although one quarter of pts had AEs leading to discontinuation of D, the majority of which occurred in the first 4 months. Consolidation D remains SoC for pts with unresectable stage III NSCLC who do not progress on definitive CRT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
theo完成签到 ,获得积分10
1秒前
allrubbish完成签到,获得积分10
9秒前
凤兮完成签到 ,获得积分10
10秒前
19秒前
过眼云烟发布了新的文献求助10
25秒前
之_ZH完成签到 ,获得积分10
27秒前
淡淡菠萝完成签到 ,获得积分10
28秒前
大饼完成签到 ,获得积分10
30秒前
36秒前
酷酷的紫南完成签到 ,获得积分10
37秒前
Ggap1发布了新的文献求助10
40秒前
你的笑慌乱了我的骄傲完成签到 ,获得积分10
41秒前
应夏山完成签到 ,获得积分10
41秒前
JasonTrue完成签到,获得积分10
42秒前
芒芒发paper完成签到 ,获得积分10
49秒前
高高高完成签到 ,获得积分10
52秒前
过眼云烟完成签到,获得积分10
55秒前
小乙猪完成签到 ,获得积分0
58秒前
大气的尔蓝完成签到,获得积分10
1分钟前
孤独剑完成签到 ,获得积分10
1分钟前
北国雪未消完成签到 ,获得积分10
1分钟前
LELE完成签到 ,获得积分10
1分钟前
快乐含烟完成签到 ,获得积分10
1分钟前
丹妮完成签到 ,获得积分10
1分钟前
HuiHui完成签到,获得积分10
1分钟前
仁者无惧完成签到 ,获得积分10
1分钟前
imica完成签到 ,获得积分10
1分钟前
醉熏的千柳完成签到 ,获得积分10
1分钟前
双眼皮跳蚤完成签到,获得积分10
1分钟前
坦率的从波完成签到 ,获得积分10
2分钟前
jtyt完成签到,获得积分10
2分钟前
sponge完成签到 ,获得积分10
2分钟前
wushuimei完成签到 ,获得积分10
2分钟前
醉熏的灵安完成签到 ,获得积分10
2分钟前
零玖完成签到 ,获得积分10
2分钟前
勤恳的TT完成签到 ,获得积分10
2分钟前
Sid完成签到,获得积分0
2分钟前
2分钟前
科研通AI2S应助Siren采纳,获得10
2分钟前
机智访琴完成签到,获得积分10
2分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968532
求助须知:如何正确求助?哪些是违规求助? 3513358
关于积分的说明 11167309
捐赠科研通 3248700
什么是DOI,文献DOI怎么找? 1794453
邀请新用户注册赠送积分活动 875030
科研通“疑难数据库(出版商)”最低求助积分说明 804664